Massimiliano Fabbiani

24PUBLICATIONS
98CO-AUTHORS
PharmacogenomicsMedical virologyInnate immunityHaematological tumoursDigital and electronic media art
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|May 15, 2026
'Leaving no stones unturned': up to 10 years results on the effectiveness, tolerability and metabolic safety of dolutegravir+lamivudine (DTG+3TC) as a switch regimen in the ODOACRE cohort.

|Dec 10, 2025
Antigen-agnostic identification of poxvirus broadly neutralizing antibodies targeting OPG153.

Ida Paciello, Emily J Rundlet, Ling Zhou

|Nov 29, 2025
Booster dose reshapes SARS-CoV-2 RBD-specific B cell immunity in people living with HIV.

Jacopo Polvere, Simone Lucchesi, Giorgio Montesi

|Jan 25, 2025
Prevalence, Incidence and Predictors of Anal HPV Infection and HPV-Related Squamous Intraepithelial Lesions in a Cohort of People Living with HIV.

Margherita Sambo, Alessandra Bailoni, Federico Mariani

|Dec 02, 2024
Predictors for choosing doravirine-based versus INSTI-based regimen in ART-naïve and ART-experienced people with HIV in real-world setting: Data from the Icona cohort.

Antonella d'Arminio Monforte, Alessandro Tavelli, Eugenia Quiros-Roldan

|Oct 06, 2024
Efficacy and Tollerability of INI-Based 2-Drug Regimen in Virosuppressed Persons Living with HIV: A Systematic Review and Meta-Analysis.

Antonio Russo, Salvatore Martini, Mariantonietta Pisaturo

Pageof 4

Frequent Collaborators

9 joint publications

Francesca Montagnani

6 joint publications

Mario Tumbarello

5 joint publications

Arturo Ciccullo

4 joint publications

Francesca Lombardi